| |
CPAP treatment
|
p-value
|
|---|
|
Overall (n = 18)
|
Before
|
After
| |
|---|
|
Right atrium mm
|
23.9 ± 3.0
|
23.7 ± 3.2
|
NS
|
|
RVFWD mm (5–8)
|
7.1 ± 2.1
|
6.2 ± 1.7
|
0.001
|
|
RVEDD mm (9–26)
|
25.4 ± 3.6
|
25.0 ± 3.3
|
NS
|
|
E-velocity (m/s)
|
0.4 ± 0.1
|
0.6 ± 0.1
|
0.0001
|
|
A-velocity (m/s)
|
0.6 ± 0.13
|
0.5 ± 0.9
|
0.001
|
|
E/A ratio (>1)*
|
0,7 ± 0.1
|
1.2 ± 0.2
|
0.0001
|
|
IVRT ms (<100)*
|
106.9 ± 24.0
|
91.1 ± 18.6
|
0.001
|
|
DT ms (<220)*
|
245.5 ± 61.0
|
210.2 ± 46.8
|
0.001
|
|
VPR cm*s-1 (>55)*
|
41.1 ± 9.9
|
60.9 ± 10.2
|
0.0001
|
|
MPI % (39 ± 5)*
|
62.2 ± 9.3
|
47.3 ± 8.4
|
0,0001
|
- Data are presented as mean ± SD. *Normal values, RVFWD: Right ventricular free wall diameter, RVEDD: Right ventricle end-diastolic diameter, E- velocity: Early tricuspid flow velocity, A- velocity: Lately tricuspid flow velocity, E/A: Ratio of early and lately tricuspid flow velocity, IVRT: Ýsovolumic relaxation time, DT: tricuspid deceleration time, VPR: Velocity of tricuspid flow propagation, MPI: Myocardial performance index of right ventricle, NS: nonsignificant.
